Fragile X Alliance Inc. and the Murdoch Childrens Research Institute are participating in a clinical trial testing a new treatment for Fragile X syndrome. The treatment is a capsule and the medication is taken twice daily for 12 weeks. To be eligible to participate in the trial, patients must fit the following criteria: Be aged [...]
Read the full article →
As a result of research into Carrier Screening, we have had a paper published in the American Journal of Medical Genetics ‘‘It’s Something I Need to Consider” Decisions About Carrier Screening for Fragile X Syndrome in a Population of Non-Pregnant Women – Archibald AD, Jaques AM, Wake S, Collins VR, Cohen J, Metcalfe SA. 2009 [...]
Read the full article →